Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)).:
SEC Accession No. 0001015820-23-000022
Filing Date
2023-05-05
Accepted
2023-05-04 21:13:55
Documents
2

Document Format Files

Seq Description Document Type Size
1 IRANNOTICE a2022q4irannotice.htm IRANNOTICE 5412
2 qiagen_logo.jpg GRAPHIC 69764
  Complete submission text file 0001015820-23-000022.txt   102050
Mailing Address HULSTERWEG 82 PL VENLO P7 5912
Business Address HULSTERWEG 82 PL VENLO P7 5912 31-77-35566-00
QIAGEN N.V. (Filer) CIK: 0001015820 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: IRANNOTICE | Act: 34 | File No.: 001-38332 | Film No.: 23890912
SIC: 2836 Biological Products, (No Diagnostic Substances)